Skip to main content
. Author manuscript; available in PMC: 2016 Mar 23.
Published in final edited form as: Leuk Res. 2011 Feb 12;35(6):814–820. doi: 10.1016/j.leukres.2010.12.028

Figure 5. Synergy with 3-BrOP and Rapamycin in pre-B and T-ALLs.

Figure 5

Average +/− SD of three samples shown in each graph. A, Decreased viability with rapamycin treatment in pre-B ALL (Nalm6 and JM1) and T-ALL (Molt4 and SupT1) lines after treatment for 72 hours. Cytotoxicity measured with AlamarBlue assay. B+C, Synergistic decrease in survival of pre-B ALL (B: Nalm6) and T-ALL (C: Molt4) cells following treatment with 3-BrOP and/or rapamycin (p=0.001–0.03) for 72 hours.